CCP
FLXN

Clough Capital Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Clough Capital Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-212,900
Closed -$1.75M – 152
2021
Q2 		$1.75M Sell
212,900
-449,506
-68% -$3.82M 0.1% 98
2021
Q1 		$5.93M Sell
662,406
-583,744
-47% -$6.69M 0.26% 78
2020
Q4 		$14.4M Hold
1,246,150
– – 1.02% 39
2020
Q3 		$13M Buy
1,246,150
+207,700
+20% +$2.55M 0.93% 40
2020
Q2 		$13.7M Buy
1,038,450
+964,550
+1,305% +$10M 1.34% 21
2020
Q1 		$582K Buy
+73,900
New +$1.11M 0.06% 91

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clough Capital Partners's FLXN Position: Q3 2021 in Review

Clough Capital Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 212,900 shares — an estimated $1.75M sold.

Clough Capital Partners first reported a position in FLXN in Q1 2020 and held it in 6 quarters. The position peaked at $14.4M in Q4 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • Clough Capital Partners reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Clough Capital Partners sold 212,900 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $1.75M.
  • Clough Capital Partners first reported a position in Flexion Therapeutics, Inc. in Q1 2020 and held it in 6 quarters.
  • Clough Capital Partners's Flexion Therapeutics, Inc. position peaked at $14.4M in Q4 2020.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Clough Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.